Prader–Willi locus Snord116 RNA processing requires an active endogenous allele and neuron-specific splicing by Rbfox3/NeuN
- 4 September 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 27 (23) , 4051-4060
Abstract
Prader-Willi syndrome (PWS), an imprinted neurodevelopmental disorder characterized by metabolic, sleep and neuropsychiatric features, is caused by the loss of paternal SNORD116, containing only non-coding RNAs (ncRNAs). The primary SNORD116 transcript is processed into small nucleolar RNAs (snoRNAs), which localize to nucleoli, and their spliced host gene 116HG, which is retained at its site of transcription. While functional complementation of the SNORD116 ncRNAs is a desirable goal for treating PWS, the mechanistic requirements of SNORD116 RNA processing are poorly understood. Here we developed and tested a novel transgenic mouse which ubiquitously expresses Snord116 on both a wild-type and a Snord116 paternal deletion (Snord116+/-) background. Interestingly, while the Snord116 transgene was ubiquitously expressed in multiple tissues, splicing of the transgene and production of snoRNAs was limited to brain tissues. Knockdown of Rbfox3, encoding neuron-specific splicing factor neuronal nuclei (NeuN) in Snord116+/--derived neurons, reduced splicing of the transgene in neurons. RNA fluorescence in situ hybridization for 116HG revealed a single significantly larger signal in transgenic mice, demonstrating colocalization of transgenic and endogenous 116HG RNAs. Similarly, significantly increased snoRNA levels were detected in transgenic neuronal nucleoli, indicating that transgenic Snord116 snoRNAs were effectively processed and localized. In contrast, neither transgenic 116HG nor snoRNAs were detectable in either non-neuronal tissues or Snord116+/- neurons. Together, these results demonstrate that exogenous expression and neuron-specific splicing of the Snord116 locus are insufficient to rescue the genetic deficiency of Snord116 paternal deletion. Elucidating the mechanisms regulating Snord116 processing and localization is essential to develop effective gene replacement therapies for PWS.Keywords
All Related Versions
Funding Information
- National Institutes of Health (R01 NS076263, R56 NS076263-06, T32 GM007377)
- Intellectual and Developmental Disabilities Research Center (U54 HD079125)
- Foundation for Prader-Willi Research
This publication has 42 references indexed in Scilit:
- Truncation of Ube3a-ATS Unsilences Paternal Ube3a and Ameliorates Behavioral Defects in the Angelman Syndrome Mouse ModelPLOS Genetics, 2013
- Alternative pre-mRNA splicing in neurons: growing up and extending its reachTrends in Genetics, 2013
- Mouse models of Prader–Willi Syndrome: A systematic reviewFrontiers in Neuroendocrinology, 2013
- Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3aHuman Molecular Genetics, 2012
- Analysis and design of RNA sequencing experiments for identifying isoform regulationNature Methods, 2010
- Splicing factor and exon profiling across human tissuesNucleic Acids Research, 2010
- Isolation, Culture, and Differentiation of Progenitor Cells from the Central Nervous SystemCold Spring Harbor Protocols, 2008
- The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3AHuman Molecular Genetics, 2001
- Paternal Deletion from Snrpn to Ube3a in the Mouse Causes Hypotonia, Growth Retardation and Partial Lethality and Provides Evidence for a Gene Contributing to Prader-Willi SyndromeHuman Molecular Genetics, 1999
- Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control regionNature Genetics, 1994